Bid #SPE2DR26FGER9. Department of Defense, Illinois. Federal contract award: 4570592619!XOLAIR 150 MG/ML SYRINGEML Awarded to: DMS PHARMACEUTICAL GROUP INC Amount: $4,737.66. Awarded to DMS PHARMACEUTICAL GROUP INC.
Department of Defense awarded this solicitation to DMS PHARMACEUTICAL GROUP INC on January 15, 2026. This page is retained as a permanent public record of the contract award; the original solicitation below is preserved as published.
Federal contract award: 4570592619!XOLAIR 150 MG/ML SYRINGEML Awarded to: DMS PHARMACEUTICAL GROUP INC Amount: $4,737.66
Department of Defense issued this medical and healthcare opportunity in Illinois, referenced as solicitation number SPE2DR26FGER9. It was published on January 15, 2026, and responses are due by February 6, 2026. The estimated contract value is approximately $4,738.
Department of Defense in Illinois is using this solicitation to procure medical work. Public buyers typically advertise this kind of work as an Invitation for Bids (IFB), Request for Proposals (RFP), or Request for Qualifications (RFQ), depending on whether the selection is price-driven, qualifications-driven, or both. Bidders responding to a medical solicitation in Illinois are generally expected to provide proof of liability insurance and workers' compensation coverage, hold any state license or trade certification required for the scope of work, and post performance and payment bonds for contracts above the agency's threshold.
Contracts of this type are usually awarded under the issuing agency's published procurement rules, with bid bond, performance bond, and reference requirements set in the solicitation documents. PublicBidSearch indexes this solicitation alongside other open bids in Illinois so contractors and vendors can compare active opportunities by category, agency, or location without monitoring each procurement portal individually.
Loading PublicBidSearch…